10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 19, 2014) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |||
| Net Cash Provided by Operating Activities [Abstract] | |||
| Cash Flows from Operating Activities | |||
| Net income | $ 4,684,800 | 4,088,600 | 4,347,700 |
| Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
| Depreciation and amortization | 1,445,600 | 1,462,200 | 1,373,600 |
| Change in deferred income taxes | 285,900 | 126,000 | (268,500) |
| Stock-based compensation expense | 144,900 | 141,500 | 147,400 |
| Impairment charges, indefinite lived intangibles | 0 | 205,000 | 151,500 |
| Acquired in-process research and development, net of tax | 37,100 | 0 | 252,200 |
| Income related to termination of the exenatide collaboration with Amylin | (495,400) | (787,800) | 0 |
| Other operating activities, net | 25,100 | 120,500 | (17,800) |
| Changes in operating assets and liabilities, net of acquisitions | |||
| Receivables - (increase) decrease | (152,700) | 361,800 | (188,800) |
| Inventories - (increase) decrease | (286,500) | (307,900) | 203,100 |
| Other assets - (increase) decrease | 116,500 | 231,000 | 642,700 |
| Accounts payable and other liabilties-increase (decrease) | (70,300) | (336,100) | 591,400 |
| Net Cash Provided by Operating Activities | 5,735,000 | 5,304,800 | 7,234,500 |
| Net Cash Provided By (Used In) Investing Activities [Abstract] | |||
| Cash Flows from Investing Activities | |||
| Purchases of property and equipment | (1,012,100) | (905,400) | (672,000) |
| Disposals of property and equipment | 179,400 | 22,000 | 25,300 |
| Proceeds from sales and maturities of short-term investments | 3,320,100 | 2,547,500 | 1,807,900 |
| Purchases of short-term investments | (1,531,000) | (2,172,400) | (2,058,800) |
| Proceeds from sales and maturities of noncurrent investments | 11,235,000 | 4,355,700 | 2,138,500 |
| Purchases of noncurrent investments | (14,041,900) | (7,618,600) | (4,459,400) |
| Purchase of product rights | (24,100) | (138,800) | (632,900) |
| Purchases of in-process research and development | (57,100) | 0 | (388,000) |
| Cash paid for acquisitions, net of cash acquired | (43,700) | (199,300) | (307,800) |
| Net change in loan to collaboration partner | 0 | 165,000 | (165,000) |
| Proceeds from prepayment of revenue-sharing obligation | 0 | 1,212,100 | 0 |
| Other investing activities, net | (97,400) | (100,600) | (112,200) |
| Net Cash Used for Investing Activities | (2,072,800) | (2,832,800) | (4,824,400) |
| Net Cash Used in Financing Activities [Abstract] | |||
| Cash Flows from Financing Activities | |||
| Dividends paid | (2,120,700) | (2,187,400) | (2,180,100) |
| Net change in short-term borrowings | 0 | 0 | (134,100) |
| Repayments of long-term debt | (10,500) | (1,511,100) | (61,700) |
| Purchases of common stock | (1,698,100) | (721,100) | 0 |
| Other financing activities, net | 0 | 0 | 6,000 |
| Net Cash Used for Financing Activities | (3,829,300) | (4,419,600) | (2,369,900) |
| Effect of exchange rate on cash and cash equivalents | (21,500) | 43,900 | (110,900) |
| Net decrease in cash and cash equivalents | (188,600) | (1,903,700) | (70,700) |
| Cash and cash equivalents at beginning of year | 4,018,800 | 5,922,500 | |
| Cash and Cash Equivalents at End of Year | 3,830,200 | 4,018,800 | 5,922,500 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |